Shanghai Runda Medical Technology Co., Ltd. Provides Earnings Guidance for the Nine Months Ended September 2018
October 11, 2018
Share
Shanghai Runda Medical Technology Co., Ltd. provided earnings guidance for the nine months ended September 2018. It is predicted that the total business revenue will be between RMB 4.1 billion and RMB 4.5 billion from January to September 2018, with a year-on-year increase of between 40% and 54%. It is predicted that the net profit belonging to the shareholders of the listed companies will be between RMB 235 million and RMB 258 million from January to September 2018, with a year-on-year increase of between 40% and 54%. The net amount of cash flow generated in production activities will be between RMB 160 million and RMB 240 million from January to September 2018, with an obvious improvement compared with net cash used in production activities Of RMB 150.39 million in the same period of the year before.
Shanghai Runda Medical Technology Co., Ltd. is a China-based company, principally engaged in the provision of in-vitro diagnostic devices and professional technique support services for all kinds of medical laboratories. The Company's integrated services include product portfolio options, professional and technical application services, informatization management of logistics warehousing distribution systems and all-round technical support. The Company also provides sales support and customer channel management, among others. The company mainly conducts its businesses within domestic market.